할인방
Clinics- 저널 단행본
디지털, 인공지능의학
동물보건사
한글도서 기초
한글도서 내과
한글도서 외과
한글도서 영상/안과/치과
한글도서 기타
기초 생명의과학
실험동물
수의 윤리/복지
기생충/산과/유전
공중보건/전염병학
독성/약리,약전
면역/미생물학
발생/해부/생리학
조직/병리학
수생동물
조류
산업/중,대동물
돼지
고양이
동물 보정,핸들링
수의 일반/기타 참고도서
소동물 내과
소동물 외과
재활/신경, 정형외과학
내시경, 자령/노령동물학
비뇨기/이비인후과
마취,통증/응급,수액
소화/영양/피부학
내분비/신경/행동학
심장,호흡기/종양학
안과/치과학
영상진단의학
임상병리(세포,혈액학)
대체의학(침술,허브)
야생/특수동물 Exo, Zoo
종보존/동물보호/법의학
병원경영/사전/용어
BSAVA 시리즈
자유결제
100자 서평
질문과 대답
  T: 042-330-0039

  042-361-2500

  HP: 010-8364-0400

  F: 042-367-1017

평일 10:00 ~ 18:00


이메일문의
신한 100-023-144280
국민 732801-01-097961
농협 453131-56-197831
하나 660-910336-13307
예금주: 이상돈 okvet
 
 
비밀번호 확인 닫기
심장,호흡기/종양학 > 심장/호흡기 > Human and Animal Filariases: Landscape, Challenges, and Control

 
Human and Animal Filariases: Landscape, Challenges, and Control
상품명 : Human and Animal Filariases: Landscape, Challenges, and Control
제조회사 : Wiley-VCH
원산지 : 독일
적립금액 : 8,490원
소비자가 : 283,000
판매가격 : 283,000원
수량 EA
 
배송조건 : (조건)
   
 

Human and Animal Filariases: Landscape, Challenges, and Control



Ronald Kaminsky (Editor), Timothy G. Geary (Editor), Paul M. Selzer (Series Editor)

ISBN: 9783527823420 

October 2022 

656 Pages

Wiley-VCH



DESCRIPTION


Human and Animal Filariases

The rational approach to controlling human and animal diseases caused by nematodes


Filariae are a family of parasitic worms which infect animals and humans, causing severe diseases such as elephantiasis (lymphatic filariasis) and river blindness (onchocerciasis) in humans, as well as heartworm disease (dirofilariasis) in dogs and cats. While the human diseases are rarely fatal, the blindness and disfiguration resulting from these infections constitute a severe burden for the affected individuals and to the healthcare systems in many tropical countries. In 2017, the World Health Organization classified several filariases as neglected tropical diseases and announced a new program seeking to eradicate these infections, which has in turn sparked a new push to develop antifilarial drugs.


Considering the current and future import of this topic, Human and Animal Filariases takes a comprehensive look at infections by filarial parasites in humans and in animals. It begins by reviewing the current state of diagnosis and chemotherapy, before addressing the increasing resistance to available antifilarial drugs. This is followed by strategies and approaches for the discovery of novel drugs and finally by looking at alternative and supplementary approaches to combat the parasites, including vector control and vaccination.


Human and Animal Filariases readers will find:


*A comprehensive approach that integrates current chemotherapy with recent advances in antifilarial drug discovery

*Practical information on assay development, target validation, and required drug product profiles

*Insights from global experts from leading academic institutions as well as from pharma and healthcare companies

Human and Animal Filariases is a unique reference for parasitologists, veterinarians, as well as professionals in the pharmaceutical industry and in public health agencies.



TABLE OF CONTENTS


PART I: Background, Status and Gaps

Filariae as organisms (including life cycles)

Human filariasis - disease and current problems

Canine filariasis (heartworm) - disease and current problems/gaps

diagnosis of human filarial infections

diagnosis of canine filarial infections

Antifilarial chemotherapy: current options (human section)

Antifilarial chemotherapy: current options (veterinary section)

Current products

Current antifilarial drug - mode of action

Drug resistance in canine filarial chemotherapy

Eradication/elimination of human filariae

The economic impact of human filariasis

The economic impact of canine filariasis


PART II: Antifilarial Drug Discovery and Development

Product profiles of new antifilarial drugs -

Discovery and development of new antifilarial drugs (in vitro assays)

Rodent models for the discovery of new antifilarial drugs

Discovery and development of new canine antifilarial drugs (in vivo assays)

Discovery and development of new human antifilarial drugs (in vivo assays)

The drug pipeline, including triple combination therapy, moxidectin, emodepside, TylaMac, auranofin


PART III: Alternative Approaches

Functional genomics of filariae

Vector control approaches: humans

Vector control approaches: canine

Drug targets at the host-parasite interface

Endosymbionts as targets

Vaccines: progress and prospects



ABOUT THE AUTHOR


Ronald Kaminsky, PhD, served as Head of Parasitology Research at Novartis Animal Health from 2006 – 2014 and is currently a consultant for antiparasitic drug discovery in the animal health sector. He teaches as a lecturer at the University of Basel and the Swiss Tropical and Public Health Institute.


Timothy G. Geary, PhD, is Emeritus Professor and past Director of the Institute of Parasitology at McGill University, Professor in the School of Biological Sciences at Queen’s University-Belfast and a consultant to many animal health companies and other organizations.


Paul M. Selzer, PhD, is currently Head of New Mechanisms Parasitology at Boehringer Ingelheim Animal Health. He is also a visiting professor at the Interfaculty Institute of Biochemistry of the University of Tübingen, DE, a teacher at the Department of Life Sciences at the University of Modena & Reggio Emilia, IT, and an honorary professor of the Department of Infection, Immunity, and Inflammation at the University of Glasgow, UK.

 
 
 
 
상호명 : OKVET 사업자등록번호 : 314-90-93001 314-90-93001 통신판매업신고번호 : 유성구청 제2006-75호
[이용약관] [개인정보 처리방침] 개인정보 보호 책임자 : 이상돈 대표 : 이상돈
사업장소재지 : 대전광역시 유성구 테크노3로 65, 한신 S-MECA 440호
Copyright ⓒ okvet All Rights Reserved. T: 042-330-0039, 042-361-2500, HP: 010-8364-0400, F: 042-367-1017